Adenovirus-vectored drug-vaccine duo as a rapid-response tool for conferring seamless protection against influenza

PLoS One. 2011;6(7):e22605. doi: 10.1371/journal.pone.0022605. Epub 2011 Jul 27.

Abstract

Few other diseases exert such a huge toll of suffering as influenza. We report here that intranasal (i.n.) administration of E1/E3-defective (ΔE1E3) adenovirus serotype 5 (Ad5) particles rapidly induced an anti-influenza state as a means of prophylactic therapy which persisted for several weeks in mice. By encoding an influenza virus (IFV) hemagglutinin (HA) HA1 domain, an Ad5-HA1 vector conferred rapid protection as a prophylactic drug followed by elicitation of sustained protective immunity as a vaccine for inducing seamless protection against influenza as a drug-vaccine duo (DVD) in a single package. Since Ad5 particles induce a complex web of host responses, which could arrest influenza by activating a specific arm of innate immunity to impede IFV growth in the airway, it is conceivable that this multi-pronged influenza DVD may escape the fate of drug resistance that impairs the current influenza drugs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenoviridae / genetics*
  • Animals
  • Antibodies, Viral / blood
  • Antiviral Agents / therapeutic use*
  • Genetic Vectors / genetics*
  • Health Status
  • Humans
  • Influenza A Virus, H1N1 Subtype / immunology
  • Influenza Vaccines / immunology*
  • Influenza, Human / drug therapy
  • Influenza, Human / immunology*
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Lung / immunology
  • Lung / pathology
  • Lung / virology
  • Mice
  • Orthomyxoviridae Infections / immunology
  • Orthomyxoviridae Infections / prevention & control
  • Orthomyxoviridae Infections / virology
  • Vaccination
  • Weight Loss

Substances

  • Antibodies, Viral
  • Antiviral Agents
  • Influenza Vaccines